Company Overview

Update
Founded:
2008
Headquarters:
Santa Barbara, CA
Funding:
$43.50M
Categories:
Biotechnology

CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.

Description

Update

CytomX Therapeutics is an early stage, privately-funded biotechnology company developing Probodiesâ„¢, proteolytically-activated antibodies. Probodies, by their ability to site-direct the activity of antibodies, will result in an improved therapeutic index for validated targets as well enable the drugging of targets with broad tissue expression. Our mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.

Current Team (8)

Update

Board Members and Advisors (5)

Update

Funding Rounds (3) - $43.50M

Update

Investors (3)

Update
  • 9f2b8ed799c4cab313f6ad0a4fb88958

    Third Rock Ventures

    Third Rock Ventures invests in transformational life science companies that show high growth..
  • B73b3303f569bcbb3b76afbb345465a4

    Roche Venture Fund

    The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company..
  • 773c0a0237bbae3861ec60373fb7001a

    Canaan Partners

    IT and Healthcare VC

Offices/Locations (1)

Update
  • Office

    460 Ward Drive

    Suite E1

    Santa Barbara, CA 93111

    USA